oa All those exanthematous fevers are not COVID-19

References

1. de Masson A, Bouaziz JD, Sulimovic L, Cassius C, Jachiet M, Ionescu MA, et al. Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France. J Am Acad Dermatol. 2020;83:667–670.
   [Google Scholar]
2. Doğanay M,Aygen B. Human brucellosis: an overview. Int J Infect Dis. 2003;(7):3–173.
   [Google Scholar]
3. Doğanay M, Meşe-Alp E. Bruselloz. Infeksiyon hastalıkları ve mikrobiyolojisi (3rd ed.). Topcu AW, Söyletir G, Doğanay M (Eds.). Nobel Tıp Kitabevleri, Istanbul. 2008, 897–909.
   [Google Scholar]
4. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069.
   [Google Scholar]
5. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020; 34:(5):e212–213.
   [Google Scholar]
6. Manalo IF, Smith MK, Cheeley J, Jacobs R. A dermatologic manifestation of COVID-19: Transient livedo reticularis. J Am Acad Dermatol. 2020; 83:(2):700.
   [Google Scholar]
7. Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;(183):1–71.
   [Google Scholar]
8. Korkmaz P, Kıdır M, Namdar ND, Özmen A, Uyar C, Değer AN. A Case of Brucellosis with Recurrent Attacks of Vasculitis. Case Rep Infect Dis. 2016 2016:5740589.
   [Google Scholar]
9. Milionis H, Christou L, Elisaf M. Cutaneous manifestations in brucellosis: case report and review of the literature. Infection. 2000; 28:(2):124–126.
   [Google Scholar]
10. Ariza J, Servitje O, Pallarés R, Fernández Viladrich P, Rufí G, Peyrí J, et al. Characteristic cutaneous lesions in patients with brucellosis. Arch Dermatol. 1989; 125:(3):380–3.
    [Google Scholar]
11. Akcali C, Savas L, Baba M, Turunc T, Seckin D Cutaneous manifestations in brucellosis: a prospective study. Adv Ther. 2007; 24:(4) 706–711.
    [Google Scholar]
12. Artuz F, Oram Y, Lenk N. Skin lesions of patients with brucellosis. Turkish Journal of Dermatology. 1994; 4: 94–96.
    [Google Scholar]
13. Metin A, Akdeniz H, Buzgan T, Delice I. Cutaneous findings encountered in brucellosis and review of the literature. Int J Dermatol. 2001; 40:(7): 434–438.
    [Google Scholar]
14. Nagore E, Sanchez-Motilla JM, Navarro V, Febrer MI,Aliaga A. Leukocytoclastic vasculitis as a cutaneous manifestation of systemic infection caused by Brucella melitensis. Cutis. 1999;:63:25–7.
    [Google Scholar]
15. Saavedra-Velasco M, Chiara-Chilet C, Pichardo-Rodriguez R, Grandez-Urbina A, Inga-Berrospi F. [Coinfection between dengue and COVID-19: need for approach in endemic zones]. Rev Fac Cien Med Univ Nac Cordoba. 2020; 77:(1):52–54.
    [Google Scholar]
16. Fan BE, Lim KGE, Chong VCL, Chan SSW, Ong KH, Kuperan P. COVID-19 and mycoplasma pneumoniae coinfection. Am J Hematol. 2020; 95:(6): 723–724.
    [Google Scholar]
17. Wu X, Cai Y, Huang X, Yu X, Zhao L, Wang F. Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China. Emerg Infect Dis. 2020; 26:(6):1324–1326.
    [Google Scholar]
18. Elzein F, Alsherbeeni N, Almatrafi K, Shosha D, Naoufel K. COVID-19 co-infection in a patient with brucella bacteremia. Respir Med Case Rep. 2020; 31: 101183. doi: 10.1016/j.rmcr.2020.101183
    [Google Scholar]